Hjem › Tripelnegativ brystkreft › New Jersey › Edison
Kliniske studier for Tripelnegativ brystkreft i Edison, NJ
11 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- START New Jersey, East Brunswick · 6 mi unna
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Rekrutterer
- Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township · 5 mi unna
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick · 3 mi unna
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RekruttererFase 3
- Rutgers Health, New Brunswick · 3 mi unna
- Regional Cancer Care Associates LLC, East Brunswick · 6 mi unna
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
RekruttererFase 2
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andre studier i Edison
- Brystkreft68 studier
- Ikke-småcellet lungekreft47 studier
- Kreft (alle typer)33 studier
- Prostatakreft29 studier
- Kolorektal kreft23 studier
- Lungekreft23 studier
- Multipelt myelom22 studier
- Blærekreft21 studier
- Akut myelogen leukemi20 studier
- Eggstokkreft20 studier
- Metastatisk kreft20 studier
- Endometriekreft19 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.